Skip to main content

Advertisement

ADVERTISEMENT

Peripheral Arterial Disease: Features

LINC 2020 Session: Latest Insights on the Safety and Efficacy of Drug-Coated Devices
Videos
01/30/2020
Dierk Scheinert, MD, and Bill Gray, MD, moderate this LINC 2020 session focusing on paclitaxel safety and with several new data releases. Featured are presentations by Drs Holden, Ouriel, Schneider, Guo, Zeller, Freisinger, and Gray.
Dierk Scheinert, MD, and Bill Gray, MD, moderate this LINC 2020 session focusing on paclitaxel safety and with several new data releases. Featured are presentations by Drs Holden, Ouriel, Schneider, Guo, Zeller, Freisinger, and Gray.
Dierk Scheinert, MD, and Bill...
01/30/2020
Vascular Disease Management
12-Month Lutonix BTK IDE Trial Results Presented at LINC 2020
Videos
01/29/2020
Featuring Patrick J. Geraghty, MD, Washington University Medical School, and Barnes-Jewish Hospital in Saint Louis, Missouri.
Featuring Patrick J. Geraghty, MD, Washington University Medical School, and Barnes-Jewish Hospital in Saint Louis, Missouri.
Featuring Patrick J. Geraghty,...
01/29/2020
Vascular Disease Management
Pedal-Plantar Loop Techniques: Lessons From a Maestro
Meeting Exclusives
01/28/2020
Below-the-ankle revascularization and the pedal-plantar loop (PPL) technique was discussed by Marco Manzi, MD, Director of the Interventional Radiology Unit at Foot & Ankle Clinic of Policlinico Abano Terme (Padua, Italy).
Below-the-ankle revascularization and the pedal-plantar loop (PPL) technique was discussed by Marco Manzi, MD, Director of the Interventional Radiology Unit at Foot & Ankle Clinic of Policlinico Abano Terme (Padua, Italy).
Below-the-ankle...
01/28/2020
Vascular Disease Management
Independent Analysis of Lutonix DCB Data Reveals No Plausible Link Between Paclitaxel and Mortality
Meeting Exclusives
01/28/2020
Kenneth Ouriel, MD, presented the latest insights into the safety and efficacy of drug-coated devices took centre stage on Tuesday morning, with a large chunk of the session dedicated to paclitaxel safety.
Kenneth Ouriel, MD, presented the latest insights into the safety and efficacy of drug-coated devices took centre stage on Tuesday morning, with a large chunk of the session dedicated to paclitaxel safety.
Kenneth Ouriel, MD, presented...
01/28/2020
Vascular Disease Management
Improving Care of CLI and Complex PAD
Interview
01/21/2020
Vascular Disease Management spoke with Richard Neville, MD, Associate Director, INOVA Heart and Vascular Institute at INOVA Health System in Falls Church, Virginia. Dr. Neville discussed the importance of a multidisciplinary approach to...
Vascular Disease Management spoke with Richard Neville, MD, Associate Director, INOVA Heart and Vascular Institute at INOVA Health System in Falls Church, Virginia. Dr. Neville discussed the importance of a multidisciplinary approach to...
Vascular Disease Management...
01/21/2020
Vascular Disease Management
Commentary Regarding Katsanos et al's Meta-Analysis: The Lessons Learned Should Impose Prudence and Caution
Commentary
01/14/2020

Francesco Liistro, MD

 

 

 

San Donato Hospital, Arezzo, Italy

Francesco Liistro, MD       San D...
Francesco Liistro, MD, comments on the meta-analysis presented by Katsanos et al.
Francesco Liistro, MD, comments on the meta-analysis presented by Katsanos et al.
Francesco Liistro, MD, comments...
01/14/2020
Vascular Disease Management
Interview
01/03/2020

Mahmood Razavi, MD

 

Director of Clinical Trials Center, St. Joseph Heart & Vascular Center, Irvine, California

Mahmood Razavi, MD   Director of Cl...
Mahmood Razavi, MD, reviewed the ASPREE trial and its implications for patients with CLI at the 2019 AMPutation Prevention Symposium in Chicago, Illinois. What were the goals of the ASPREE trial? 
Mahmood Razavi, MD, reviewed the ASPREE trial and its implications for patients with CLI at the 2019 AMPutation Prevention Symposium in Chicago, Illinois. What were the goals of the ASPREE trial? 
Mahmood Razavi, MD, reviewed the...
01/03/2020
Vascular Disease Management
Interview
01/03/2020

Lawrence Garcia, MD

 

St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts

Lawrence Garcia, MD   St. Elizabeth...
Lawrence Garcia, MD, discusses hypertensive therapy for CLI patients, as well as the importance of managing CLI patients from a global perspective.
Lawrence Garcia, MD, discusses hypertensive therapy for CLI patients, as well as the importance of managing CLI patients from a global perspective.
Lawrence Garcia, MD, discusses...
01/03/2020
Vascular Disease Management
Clinical Trial Update
12/09/2019

William A. Gray, MD, FACC, FSCAI

 

System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania

William A. Gray, MD, FACC, FSCAI   ...
Vascular Disease Management talks with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.
Vascular Disease Management talks with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.
Vascular Disease Management...
12/09/2019
Vascular Disease Management
Case Report
12/04/2019

Mason D. Nagel, BS1; George Adams, MD, MHS, FACC2

 

1NCSU of Raleigh, North Carolina ;2UNC Rex Hospital of Raleigh, North Carolina

Mason D. Nagel, BS1; George Adams, MD...
Nagel and Adams describe a case that utilizes a personalized approach for access, crossing, and treatment in order to achieve the best outcomes for the patient.
Nagel and Adams describe a case that utilizes a personalized approach for access, crossing, and treatment in order to achieve the best outcomes for the patient.
Nagel and Adams describe a case...
12/04/2019
Vascular Disease Management

Advertisement

Advertisement

Advertisement